New pill offers hope for stubborn anemia in rare blood disease
NCT ID NCT07052838
Summary
This study tested whether a new tablet called HSK39297 could help patients with a rare blood disease called PNH who still have low red blood cell counts (anemia) despite being on standard antibody therapy. The goal was to see if the tablet could safely raise hemoglobin levels enough to avoid the need for blood transfusions. The trial involved 36 adult patients who had been on stable standard treatment for at least six months but still had significant anemia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
-
The First Affiliated Hospital, College of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.